Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | 2927-2930 |
| Seitenumfang | 4 |
| Fachzeitschrift | ChemBioChem |
| Jahrgang | 21 |
| Ausgabenummer | 20 |
| Frühes Online-Datum | 2 Juni 2020 |
| Publikationsstatus | Veröffentlicht - 15 Okt. 2020 |
Abstract
A multiblocked mutant strain (ΔAHBA and Δasm12, asm21) of Actinosynnema pretiosum, the producer of the highly toxic maytansinoid ansamitocin, has been used for the mutasynthetic production of new proansamitocin derivatives. The use of mutant strains that are blocked in the biosynthesis of an early building block as well as in the expression of two tailoring enzymes broadens the scope of chemo-biosynthetic access to new maytansinoids. Remarkably, a ring-expanded macrolactone derived from ansamitocin was created for the first time.
ASJC Scopus Sachgebiete
- Biochemie, Genetik und Molekularbiologie (insg.)
- Biochemie
- Biochemie, Genetik und Molekularbiologie (insg.)
- Molekularmedizin
- Biochemie, Genetik und Molekularbiologie (insg.)
- Molekularbiologie
- Chemie (insg.)
- Organische Chemie
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: ChemBioChem, Jahrgang 21, Nr. 20, 15.10.2020, S. 2927-2930.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - First ring-expanded maytansin lactone accessed by a new mutasynthetic variant
AU - Wesemann, Friederike
AU - Heutling, Anja
AU - Wienecke, Paul
AU - Kirschning, Andreas
PY - 2020/10/15
Y1 - 2020/10/15
N2 - A multiblocked mutant strain (ΔAHBA and Δasm12, asm21) of Actinosynnema pretiosum, the producer of the highly toxic maytansinoid ansamitocin, has been used for the mutasynthetic production of new proansamitocin derivatives. The use of mutant strains that are blocked in the biosynthesis of an early building block as well as in the expression of two tailoring enzymes broadens the scope of chemo-biosynthetic access to new maytansinoids. Remarkably, a ring-expanded macrolactone derived from ansamitocin was created for the first time.
AB - A multiblocked mutant strain (ΔAHBA and Δasm12, asm21) of Actinosynnema pretiosum, the producer of the highly toxic maytansinoid ansamitocin, has been used for the mutasynthetic production of new proansamitocin derivatives. The use of mutant strains that are blocked in the biosynthesis of an early building block as well as in the expression of two tailoring enzymes broadens the scope of chemo-biosynthetic access to new maytansinoids. Remarkably, a ring-expanded macrolactone derived from ansamitocin was created for the first time.
KW - ansamitocin
KW - macrolactones
KW - maytansinoids
KW - mutasynthesis
KW - proansamitocins
UR - http://www.scopus.com/inward/record.url?scp=85087292782&partnerID=8YFLogxK
U2 - 10.1002/cbic.202000336
DO - 10.1002/cbic.202000336
M3 - Article
C2 - 32484951
AN - SCOPUS:85087292782
VL - 21
SP - 2927
EP - 2930
JO - ChemBioChem
JF - ChemBioChem
SN - 1439-4227
IS - 20
ER -